HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma.

Abstract
Chemerin is a chemoattractant involved in innate and adaptive immunity as well as an adipokine implicated in adipocyte differentiation. Chemerin circulates as an inactive precursor in blood whose bioactivity is closely regulated through proteolytic processing at its C terminus. We developed methodology for production of different recombinant chemerin isoforms (chem163S, chem157S, and chem155A) which allowed us to obtain large quantities of these proteins with purity of >95%. Chem158K was generated from chem163S by plasmin cleavage. Characterization by mass spectrometry and Edman degradation demonstrated that both the N and C termini were correct for each isoform. Ca(2+) mobilization assays showed that the EC(50) values for chem163S and chem158K were 54.2 ± 19.9 nm and 65.2 ± 13.2 nm, respectively, whereas chem157S had a ∼50-fold higher potency with an EC(50) of 1.2 ± 0.7 nm. Chem155A had no agonist activity and weak antagonist activity, causing a 50% reduction of chem157S activity at a molar ratio of 100:1. Similar results were obtained in a chemotaxis assay. Because chem158K is the dominant form in cerebrospinal fluid from patients with glioblastoma (GBM), we examined the significance of chemerin in GBM biology. In silico analysis showed chemerin mRNA was significantly increased in tissue from grade III and IV gliomas. Furthermore, U-87 MG cells, a human GBM line, express the chemerin receptors, chemokine-like receptor 1 and chemokine receptor-like 2, and chem157S triggered Ca(2+) flux. This study emphasized the necessity of appropriate C-terminal proteolytic processing to generate the likely physiologic form of active chemerin, chem157S, and suggested a possible role in malignant GBM.
AuthorsYasuto Yamaguchi, Xiao-Yan Du, Lei Zhao, John Morser, Lawrence L K Leung
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 286 Issue 45 Pg. 39510-9 (Nov 11 2011) ISSN: 1083-351X [Electronic] United States
PMID21949124 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • CMKLR1 protein, human
  • Chemokines
  • Intercellular Signaling Peptides and Proteins
  • Neoplasm Proteins
  • Protein Isoforms
  • RARRES2 protein, human
  • RNA, Messenger
  • RNA, Neoplasm
  • Receptors, Chemokine
  • Recombinant Proteins
  • Fibrinolysin
Topics
  • Animals
  • CHO Cells
  • Chemokines (chemistry, genetics, metabolism)
  • Cricetinae
  • Cricetulus
  • Fibrinolysin (chemistry)
  • Gene Expression Regulation, Neoplastic
  • Glioblastoma (genetics, metabolism)
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Neoplasm Proteins (genetics, metabolism)
  • Protein Isoforms (chemistry, genetics, metabolism)
  • Protein Structure, Tertiary
  • Proteolysis
  • RNA, Messenger (biosynthesis, genetics)
  • RNA, Neoplasm (biosynthesis, genetics)
  • Receptors, Chemokine (biosynthesis, genetics)
  • Recombinant Proteins (chemistry, genetics, metabolism)
  • Signal Transduction
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: